Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 12,520.00p on 23-09-2026 at 10:19:38
Change -152.00p -1.2%
Buy 12,520.00p
Sell 12,518.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 0.00 at 12,518.00p
Day's Volume: 264,669
Last Close: 12,672.00p
Open: 12,564.00p
ISIN: GB0009895292
Day's Range 12,468.00p - 12,660.00p
52wk Range: 10,784.00p - 15,730.00p
Market Capitalisation: £194.17b
VWAP: 12,566.78525p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 12,518.00p SI Trade
 11:19:38 - 23-Sep-26
Sell* 63 12,520.00p Automatic Execution
 11:19:25 - 23-Sep-26
Sell* 106 12,520.00p Automatic Execution
 11:19:25 - 23-Sep-26
Sell* 63 12,520.00p Automatic Execution
 11:19:25 - 23-Sep-26
Sell* 1 12,520.00p Automatic Execution
 11:19:25 - 23-Sep-26
Sell* 252 12,520.00p Automatic Execution
 11:19:25 - 23-Sep-26
Sell* 76 12,520.00p Automatic Execution
 11:19:25 - 23-Sep-26
Sell* 20 12,522.00p Automatic Execution
 11:19:23 - 23-Sep-26
Sell* 43 12,522.00p Automatic Execution
 11:19:23 - 23-Sep-26
Sell* 15 12,522.00p Automatic Execution
 11:19:23 - 23-Sep-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
22nd Sep 2026 (Tue) 12,606.00 12,688.00 12,478.00 12,672.00 4,821,323
21st Sep 2026 (Mon) 12,450.00 12,630.00 12,364.00 12,560.00 3,916,309
18th Sep 2026 (Fri) 12,460.00 12,596.00 12,398.00 12,500.00 6,542,628
17th Sep 2026 (Thu) 12,202.00 12,428.00 12,148.00 12,428.00 2,814,932
16th Sep 2026 (Wed) 12,098.00 12,296.00 12,074.00 12,136.00 5,326,814
15th Sep 2026 (Tue) 12,236.00 12,236.00 11,922.00 12,116.00 3,056,568
14th Sep 2026 (Mon) 11,698.00 12,216.00 11,692.00 12,154.00 6,469,579
11th Sep 2026 (Fri) 11,810.00 11,960.00 11,708.00 11,708.00 1,474,394
10th Sep 2026 (Thu) 11,634.00 11,802.00 11,552.00 11,758.00 2,069,750
9th Sep 2026 (Wed) 11,850.00 11,996.00 11,598.00 11,650.00 3,565,541
8th Sep 2026 (Tue) 11,958.00 12,122.00 11,852.00 11,876.00 2,301,862
7th Sep 2026 (Mon) 11,986.00 12,210.00 11,952.00 12,042.00 1,975,838
4th Sep 2026 (Fri) 12,146.00 12,206.00 11,986.00 12,006.00 2,248,244
3rd Sep 2026 (Thu) 12,066.00 12,290.00 12,018.00 12,146.00 2,393,791
2nd Sep 2026 (Wed) 12,032.00 12,194.00 11,846.00 11,976.00 2,765,667
1st Sep 2026 (Tue) 11,650.00 12,132.00 11,650.00 11,962.00 2,914,001
31st Aug 2026 (Mon) 11,970.00 11,970.00 11,970.00 11,970.00 0
28th Aug 2026 (Fri) 12,200.00 12,200.00 11,960.00 11,970.00 3,627,372
27th Aug 2026 (Thu) 12,194.00 12,236.00 12,066.00 12,114.00 3,580,331
26th Aug 2026 (Wed) 12,450.00 12,462.00 12,214.00 12,234.00 2,783,597
25th Aug 2026 (Tue) 12,220.00 12,476.00 12,124.00 12,476.00 2,035,709
24th Aug 2026 (Mon) 12,182.00 12,204.00 12,016.00 12,110.00 1,791,143
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
21st Sep 2026 7:05 am RNS Klygefa recommended for EU approval by CHMP
21st Sep 2026 7:00 am RNS Enhertu recommended for approval in EU in early BC
18th Sep 2026 11:00 am RNS Director/PDMR Shareholding
15th Sep 2026 3:05 pm RNS Director/PDMR Shareholding
15th Sep 2026 3:00 pm RNS Director/PDMR Shareholding
14th Sep 2026 7:00 am RNS Update on SERENA-4 Phase III trial
8th Sep 2026 2:00 pm RNS Imfinzi+Imdelltra improved OS in small cell lung
7th Sep 2026 7:00 am RNS Etcamah approved in the US for HR+ breast cancer
1st Sep 2026 3:05 pm RNS Admission of Further Securities to Trading
1st Sep 2026 3:00 pm RNS Total Voting Rights
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

AstraZeneca celebrates EU approval of Trixeo for treating asthma

23rd Sep 2026 08:56

(Alliance News) - AstraZeneca PLC on Wednesday said the EU approved Trixeo Aerosphere for the maintenance treatment of asthma. Read More

LONDON BRIEFING: Airtel eyes major IPO; JD Sports holds guidance

23rd Sep 2026 07:59

(Alliance News) - Airtel Africa's mobile money business plans what could be one of London's biggest IPOs in recent years. JD Sports reports a sharp fall in adjusted first-half profit but maintains its annual guidance, while Diageo appoints WPP's Joanne Wilson as its new chief financial officer. Read More

LONDON MARKET CLOSE: FTSE 100 slides as bond yields resume upward path

18th Sep 2026 17:02

(Alliance News) - The FTSE 100 fell heavily on Friday as bond yields pushed higher amid fears that higher inflation will keep interest rates elevated. Read More

AstraZeneca drug Klygefa gains positive opinion from EU's CHMP

18th Sep 2026 15:27

(Alliance News) - AstraZeneca PLC on Friday announced that Klygefa has been recommended for approval in the EU, as a treatment for generalised myasthenia gravis. Read More

AstraZeneca, Daiichi celebrate another recommended approval of Enhertu

18th Sep 2026 14:04

(Alliance News) - AstraZeneca PLC and its partner Daiichi Sankyo Co Ltd on Friday announced that their cancer drug Enhertu has been recommended to be approved in the EU for a form of breast cancer. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,718.08
Change9.75

Login to your account

Forgot Password?

Not Registered